Denosumab Versus Risedronate in Glucocorticoid-Induced Osteoporosis: Final Results of a Twenty-Four-Month Randomized, Double-Blind, Double-Dummy Trial - Saag, K G; Pannacciulli, N; Geusens, P (Arthritis Rheumatol, 2019)